Method of diagnosing, monitoring, staging, imaging and treating colon cancer

View Patent ↗

Loading inventors, assignments & file history…

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Order via The Patent Place →

Pre-filled with this patent's details

Quick Facts

Patent No.: US 6,858,386
App. No.: 09/618,596
Granted: Feb 22, 2005
Kind: B1

External Links

USPTO Patent Center↗ Full Patent PDF↗

Abstract

The present invention provides new methods for detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating colon cancer.

Claims (3)

1. A method for detecting the presence of colon cancer in a patient comprising

(a) determining levels of a polynucleotide comprising SEQ ID NO:1 or a polypeptide encoded thereby, in cells, tissues or bodily fluids in a patient; and

(b) comparing the determined levels of the polynucleotide comprising SEQ ID NO:1 or the polypeptide encoded thereby with levels of the polypeptide comprising SEQ ID NO:1 or the polypeptide encoded thereby in cells, tissues or bodily fluids measured in a normal human control, wherein a change in determined levels of the polynucleotide comprising SEQ ID NO:1 or the polypeptide encoded thereby in said patient versus levels of the polynucleotide comprising SEQ ID NO:1 or the polypeptide encoded thereby measured in a normal human control is associated with the presence of colon cancer.

Assignments (5)

ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 7, 2017

From: GENERAL ATOMICS

To: DIAZYME LABORATORIES, INC.

Reel/Frame 041651/0661 →

ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 4, 2017

From: DIADEXUS, INC.

To: GENERAL ATOMICS

Reel/Frame 041245/0899 →

CHANGE OF NAME Recorded Dec 28, 2016

From: DIADEXUS, INC.

To: DIADEXUS, INC.